TLR3 and myeloid sarcoma: MS astrocytes have been exposed to the pathological environment and have encountered pro-inflammatory cytokines that may have altered their fibronectin splicing as well as TLR3 agonists, which may explain their ability to form fibronectin aggregates in vitro in the absence of TLR3 agonists.